Exelixis Stock Price (NASDAQ:EXEL)

Add to My Stocks
$29.18 $0.6 (2.01%) EXEL stock closing price Feb 16, 2018 (Closing)
Prev Close* : $29.78
Market Cap:
Day Low: $29.13
52 Week Low: $18.03
Open: $29.67
Volume: -
Day High: $29.78
52 Week High: $32.50

Latest Stock Market News

Latest Articles

Exelixis News - From Partners

EXEL Stockcharts

View EXEL PE ratio, PS ratio stocks charts and compare with peers.
EXEL Chart
Note: Compare Exelixis stock price history with the index and industry peers.

Exelixis Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Exelixis Returns

(return on equity)

Exelixis Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

EXEL Industry Peers

Company Price Change (%)
Bluebird Bio (BLUE)213.354.7 (2.25%)
Synageva Biopharma (GEVA)238.60 (0%)
Sanofi (SNY)39.910.19 (0.48%)
Swedish Orphan (SWTUY)16.30 (0%)
Amgen (AMGN)183.550.05 (0.03%)
Pfizer (PFE)36.260.55 (1.54%)
Swedish Orphan (SWTUY)16.30 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Novavax (NVAX)2.340.18 (8.33%)
Fate Therapeutics (FATE)8.760.65 (8.01%)
Dicerna Pharma (DRNA)10.630.57 (5.67%)
Alkermes (ALKS)67.263.51 (5.51%)
AVID BIOSERVICS (CDMO)2.490.12 (5.06%)
Achillion Pharma (ACHN)3.20.13 (4.23%)
NewLink Genetics (NLNK)7.110.27 (3.95%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Cytokinetics (CYTK)8.0250.63 (7.28%)
MiMedx (MDXG)14.470.96 (6.22%)
Catalyst Biosciences (CBIO)31.082.01 (6.07%)
Advaxis (ADXS)2.510.13 (4.92%)
Insmed (INSM)24.231.14 (4.49%)
Amicus Therapeutics (FOLD)15.170.66 (4.17%)
Alder BioPharma (ALDR)13.550.5 (3.56%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 17, 2018

Exelixis, Inc. Stock News - Partner Headlines

Exelixis Financial Statements

income statement20162015201420132012
Net Sales or Revenues191.45M37.17M25.11M31.33M47.45M
Net Income-70.22M-169.73M-268.54M-244.76M-147.64M
Total Operating Expense213.01M154.69M247.52M230.94M169.87M
View Exelixis income statement
balance sheet20162015201420132012
Total Assets597.54M332.34M327.96M503.28M721.09M
Total Liabilities508.22M436.64M442.78M437.04M424.66M
Shareholders Equity89.31M-104.3M-114.82M66.23M296.43M
View Exelixis balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities227.26M-25.84M-10.27M-2.26M-8.63M
Net Cash from (used by) Operating Activities206.29M-141.58M-235.4M-198.77M-123.14M
Increase (Decrease) in Prop Plant And Equipment-1.6M--0.08M-2.02M-0.77M
View Exelixis cash flow statement

Exelixis Stock Message Board

Exelixis stock lost 2.01%, and the last close price as of Feb 16, 2018 is $29.18 for EXEL stock. The total market value as denoted by $8.63B for Exelixis, is the market value of the company's outstanding shares. Exelixis valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Exelixis is worth a lot, it will most likely be reflected in an inflated Exelixis stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 1,490,441 on the last trading day, as is evident from Exelixis stock chart, and EXEL stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Exelixis dividend per share was 0.00 during the last quarter. Exelixis stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.